Fatty liver disease (MASLD/MASH): open trials in Belgium

17 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Hopital Erasme, Anderlecht · Antwerp University Hospital, Edegem · Ziekenhuis Oost-Limburg, Genk · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Sante et Prevoyance, Namur · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Hopital Erasme, Anderlecht · Antwerp University Hospital, Edegem · Ziekenhuis Oost-Limburg, Genk · Centre Hospitalier Universitaire de Liège, Liège
Registry updated 2026-10-28
2024-512895-36-00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Trial Treatment · Phase 3 · Akero Therapeutics Inc.
Hopital Erasme, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent
Registry updated 2026-10-23
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hopital Erasme, Anderlecht · CHU Brugmann, Brussels · Antwerp University Hospital, Edegem · Ziekenhuis Oost-Limburg, Genk · Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hopital Erasme, Anderlecht · Antwerp University Hospital, Edegem · Ziekenhuis Oost-Limburg, Genk · Az Maria Middelares Gent, Gent · UZ Brussel, Jette · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-23
2026-525755-82-00
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Hopital Erasme, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-19
2026-525757-37-00
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Hopital Erasme, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-19
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Université Libre de Bruxelles - Hôpital Erasme, Brussels · Cliniques universitaires Saint-Luc, Brussels · UZ Brussel, Brussels · Centre Hospitalier Universitaire Brugmann, Brussels · Antwerp University Hospital, Edegem · UZ Gent, Ghent · AZ Maria Middelares, Ghent · AZ Groeninge Campus Kennedylaan, Kortrijk · AZ Oostende vzw, Ostend · AZ Delta vzw, Roeselare · Vitaz, Sint-Niklaas
Registry updated 2026-10-08
NCT07221188
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Hopital Erasme, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-17
NCT06506513
Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease
Trial Treatment · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Cliniques universitaires Saint-Luc, Brussels · Centre d'investigation clinique en nutrition, Louvain-la-Neuve
Registry updated 2026-07-14
NCT06575400
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Trial Treatment · Phase 1 · Boehringer Ingelheim
SGS Life Science Services - Clinical Research, Edegem
Registry updated 2026-07-07
2024-513549-36-01
A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH
Trial Treatment · Phase 1 · Boehringer Ingelheim International GmbH
SGS Belgium, Edegem
Registry updated 2026-05-13
NCT06445361
Prevalence of NAFLD in T1DM Patients
Trial Treatment · Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg, Genk
Registry updated 2025-07-28
NCT06814600
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
Research · Centre Hospitalier Universitaire Saint Pierre
CHU Saint-Pierre, Brussels
Registry updated 2025-02-07
NCT05651724
Global Research Initiative for Patients Screening on MASH
Research · Julius Clinical
Antwerp University Hospital, Antwerp · Hôpital Erasme - Cliniques universitaires de Bruxelles, Brussels
Registry updated 2024-08-01
NCT05309863
Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease
Research · University Hospital, Ghent
Zeepreventorium, De Haan · AZ Jan Palfijn, Ghent · University Hospital Gent, Ghent
Registry updated 2024-06-04
NCT04442334
The European NAFLD Registry
Research · Newcastle University
Universitair Ziekenhuis Antwerpen, Antwerp
Registry updated 2023-01-06

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error